Cargando…
Theiler's Murine Encephalomyelitis Virus as a Vaccine Candidate for Immunotherapy
The induction of sterilizing T-cell responses to tumors is a major goal in the development of T-cell vaccines for treating cancer. Although specific components of anti-viral CD8+ immunity are well characterized, we still lack the ability to mimic viral CD8+ T-cell responses in therapeutic settings f...
Autores principales: | Pavelko, Kevin D., Girtman, Megan A., Mitsunaga, Yoshihiro, Mendez-Fernandez, Yanice V., Bell, Michael P., Hansen, Michael J., Allen, Kathleen S., Rodriguez, Moses, Pease, Larry R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098865/ https://www.ncbi.nlm.nih.gov/pubmed/21625449 http://dx.doi.org/10.1371/journal.pone.0020217 |
Ejemplares similares
-
Pathogenesis of Theiler's Murine Encephalomyelitis Virus
por: Yamada, Masahito, et al.
Publicado: (1991) -
Characterization of Ribosomal Frameshifting in Theiler's Murine Encephalomyelitis Virus
por: Finch, Leanne K., et al.
Publicado: (2015) -
Nonequivalence of Classical MHC Class I Loci in Ability to Direct Effective Antiviral Immunity
por: Pavelko, Kevin D., et al.
Publicado: (2012) -
Characterization of the stimulators of protein-directed ribosomal frameshifting in Theiler's murine encephalomyelitis virus
por: Napthine, Sawsan, et al.
Publicado: (2019) -
TDP-43 proteinopathy in Theiler’s murine encephalomyelitis virus
infection
por: Masaki, Katsuhisa, et al.
Publicado: (2019)